应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NRIX Nurix Therapeutics
未开盘 04-22 16:00:00 EDT
11.46
+0.91
+8.63%
盘后
11.74
+0.28
+2.44%
19:39 EDT
最高
11.51
最低
10.68
成交量
114.95万
今开
10.73
昨收
10.55
日振幅
7.87%
总市值
8.74亿
流通市值
6.78亿
总股本
7,624万
成交额
1,285万
换手率
1.94%
流通股本
5,912万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%
市场透视 · 04-22 15:43
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%
Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元
市场透视 · 04-21 14:39
Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元
市场透视 · 04-16
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元
Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%
市场透视 · 03-03
Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%
Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%
市场透视 · 02-27
Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元
市场透视 · 02-25
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元
Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元
市场透视 · 02-11
Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元
Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元
市场透视 · 02-05
Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元
Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元
市场透视 · 02-03
Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元
Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%
市场透视 · 01-30
Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%
加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。
金融界 · 01-29
加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。
小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。
金融界 · 01-29
小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。
Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。
金融界 · 01-29
Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。
HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。
金融界 · 01-29
HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。
Nurix Therapeutics(NRIX.US):2024年Q4财报实现营收1328.4万美元,前值为1515.9万美元,预期值为1285.9万美元;每股收益为-0.75美元,前值为-0.77美元,预期值为-0.71美元。
金融界 · 01-28
Nurix Therapeutics(NRIX.US):2024年Q4财报实现营收1328.4万美元,前值为1515.9万美元,预期值为1285.9万美元;每股收益为-0.75美元,前值为-0.77美元,预期值为-0.71美元。
Nurix Therapeutics第四季度每股收益$(0.75)不及预期$(0.68),销售额$1328万超过预期$1286万
财报速递 · 01-28
Nurix Therapeutics第四季度每股收益$(0.75)不及预期$(0.68),销售额$1328万超过预期$1286万
Nurix Therapeutics, Inc.盘中异动 急速拉升5.86%
市场透视 · 01-15
Nurix Therapeutics, Inc.盘中异动 急速拉升5.86%
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.18%报18.50美元
市场透视 · 01-10
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.18%报18.50美元
Nurix Therapeutics, Inc.盘中异动 股价大跌5.12%报18.91美元
市场透视 · 2024-12-27
Nurix Therapeutics, Inc.盘中异动 股价大跌5.12%报18.91美元
加载更多
公司概况
公司名称:
Nurix Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库,该公司已经建立了一个集成的发现平台DELigase,以识别和开发针对E3连接酶的新药物候选。
发行价格:
--
{"stockData":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":11.46,"timestamp":1745352000000,"preClose":10.55,"halted":0,"volume":1149457,"hourTrading":{"tag":"盘后","latestPrice":11.74,"preClose":11.46,"latestTime":"19:39 EDT","volume":20808,"amount":238544.87,"timestamp":1745365179342},"delay":0,"floatShares":59121976,"shares":76235594,"eps":-2.805453,"marketStatus":"未开盘","change":0.91,"latestTime":"04-22 16:00:00 EDT","open":10.73,"high":11.51,"low":10.68,"amount":12845793.486124001,"amplitude":0.078673,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.805453,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":10.55,"preHourTrading":{"tag":"盘前","latestPrice":10.75,"preClose":10.55,"latestTime":"09:29 EDT","volume":938,"amount":10086.579923,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":11.74,"preClose":11.46,"latestTime":"19:39 EDT","volume":20808,"amount":238544.87,"timestamp":1745365179342},"volumeRatio":1.048163,"impliedVol":1.0062,"impliedVolPercentile":0.7952},"requestUrl":"/m/hq/s/NRIX","defaultTab":"news","newsList":[{"id":"2529352935","title":"Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529352935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529352935?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:43","pubTimestamp":1745336605,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时43分,Nurix Therapeutics, Inc.股票出现异动,股价急速上涨5.31%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.83%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422234325aa2c7683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422234325aa2c7683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2529338536","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529338536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529338536?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:39","pubTimestamp":1745246371,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时39分,Nurix Therapeutics, Inc.股票出现波动,股价急速上涨5.47%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223932a4613096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223932a4613096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","BK4007","LENZ"],"gpt_icon":0},{"id":"2527724493","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527724493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527724493?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:08","pubTimestamp":1744812494,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时08分,Nurix Therapeutics, Inc.股票出现波动,股价急速跳水5.19%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.41%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220814a6bcabc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220814a6bcabc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","NRIX"],"gpt_icon":0},{"id":"2516658359","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658359?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:35","pubTimestamp":1741016156,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时35分,Nurix Therapeutics, Inc.股票出现异动,股价急速跳水5.18%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.36%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032335579637bcd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032335579637bcd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2514331683","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514331683?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:39","pubTimestamp":1740677995,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时39分,Nurix Therapeutics, Inc.股票出现异动,股价大幅下跌5.10%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801395598953419&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801395598953419&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2514726011","title":"Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514726011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514726011?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:38","pubTimestamp":1740501495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时38分,Nurix Therapeutics, Inc.股票出现异动,股价大幅跳水5.04%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600381696300d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600381696300d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2510353845","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510353845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510353845?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:07","pubTimestamp":1739297270,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时07分,Nurix Therapeutics, Inc.股票出现波动,股价大幅下挫5.00%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.46%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212020751961f6c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212020751961f6c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2509231285","title":"Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231285?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:24","pubTimestamp":1738776295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时24分,Nurix Therapeutics, Inc.股票出现异动,股价急速拉升5.00%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.06%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012455a23aa149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012455a23aa149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2508178878","title":"Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508178878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508178878?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:44","pubTimestamp":1738615480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时44分,Nurix Therapeutics, Inc.股票出现波动,股价大幅跳水5.07%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204044440abc15275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204044440abc15275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2507692295","title":"Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507692295","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507692295?lang=zh_cn&edition=full","pubTime":"2025-01-30 12:01","pubTimestamp":1738209666,"startTime":"0","endTime":"0","summary":"1月30日,Nurix Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.94亿美元,同比减少34.72%;其中营业收入为54.55百万美元,同比减少29.15%,每股基本收益为-2.88美元。机构评级:截至2025年1月30日,当前有17家机构对Nurix Therapeutics, Inc.目标价做出预测,其中目标均价为33.18美元,其中最低目标价为26.00美元,最高目标价为41.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130120118a233ed05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130120118a233ed05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2507659941","title":"加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507659941","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507659941?lang=zh_cn&edition=full","pubTime":"2025-01-30 01:36","pubTimestamp":1738172215,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30013647899048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NRIX"],"gpt_icon":0},{"id":"2507398356","title":"小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507398356","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507398356?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:04","pubTimestamp":1738159446,"startTime":"0","endTime":"0","summary":"小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29220447898251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2507633778","title":"Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507633778","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507633778?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:22","pubTimestamp":1738156968,"startTime":"0","endTime":"0","summary":"Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29212247898164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2507843680","title":"HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507843680","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507843680?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:20","pubTimestamp":1738153253,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29202047897457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NRIX"],"gpt_icon":0},{"id":"2507522389","title":"Nurix Therapeutics(NRIX.US):2024年Q4财报实现营收1328.4万美元,前值为1515.9万美元,预期值为1285.9万美元;每股收益为-0.75美元,前值为-0.77美元,预期值为-0.71美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507522389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507522389?lang=zh_cn&edition=full","pubTime":"2025-01-29 06:20","pubTimestamp":1738102841,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics(NRIX.US):2024年Q4财报实现营收1328.4万美元,前值为1515.9万美元,预期值为1285.9万美元;每股收益为-0.75美元,前值为-0.77美元,预期值为-0.71美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29062047883837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"1123609217","title":"Nurix Therapeutics第四季度每股收益$(0.75)不及预期$(0.68),销售额$1328万超过预期$1286万","url":"https://stock-news.laohu8.com/highlight/detail?id=1123609217","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123609217?lang=zh_cn&edition=full","pubTime":"2025-01-29 05:02","pubTimestamp":1738098146,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics 报告季度每股亏损$,未达到分析师普遍预期的$,相差10.29%。这比去年同期每股亏损$增加了2.6%。公司报告季度销售额为1328万美元,超过分析师普遍预期的1286万美元,超出3.31%。以上内容来自Benzinga Earnings专栏,原文如下:$Nurix Therapeutics$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 10.29 percent. This is a 2.6 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $13.28 million which beat the analyst consensus estimate of $12.86 million by 3.31 percent. T","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nurix Therapeutics第四季度每股收益$(0.75)不及预期$(0.68),销售额$1328万超过预期$1286万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX"],"gpt_icon":0},{"id":"2503642954","title":"Nurix Therapeutics, Inc.盘中异动 急速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642954?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951475,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分,Nurix Therapeutics, Inc.股票出现波动,股价大幅拉升5.86%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311598673ae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311598673ae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2502988968","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.18%报18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502988968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502988968?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:00","pubTimestamp":1736521222,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时00分,Nurix Therapeutics, Inc.股票出现波动,股价急速跳水5.18%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300239861efd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300239861efd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ"],"gpt_icon":0},{"id":"2494335654","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.12%报18.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494335654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494335654?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:38","pubTimestamp":1735321092,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时38分,Nurix Therapeutics, Inc.股票出现异动,股价大幅下跌5.12%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.65%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228013812a20c239b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228013812a20c239b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nurixtx.com","stockEarnings":[{"period":"1week","weight":0.167},{"period":"1month","weight":-0.1178},{"period":"3month","weight":-0.4177},{"period":"6month","weight":-0.5456},{"period":"1year","weight":-0.1561},{"period":"ytd","weight":-0.3917}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库,该公司已经建立了一个集成的发现平台DELigase,以识别和开发针对E3连接酶的新药物候选。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.063877},{"month":2,"riseRate":0.2,"avgChangeRate":-0.007659},{"month":3,"riseRate":0.2,"avgChangeRate":-0.071924},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044617},{"month":5,"riseRate":0.5,"avgChangeRate":0.018484},{"month":6,"riseRate":0.5,"avgChangeRate":0.129707},{"month":7,"riseRate":0.75,"avgChangeRate":0.109681},{"month":8,"riseRate":0.6,"avgChangeRate":0.053338},{"month":9,"riseRate":0.2,"avgChangeRate":0.013466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0754},{"month":11,"riseRate":0.4,"avgChangeRate":0.106468},{"month":12,"riseRate":0.4,"avgChangeRate":0.034689}],"exchange":"NASDAQ","name":"Nurix Therapeutics","nameEN":"Nurix Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nurix Therapeutics,NRIX,Nurix Therapeutics股票,Nurix Therapeutics股票老虎,Nurix Therapeutics股票老虎国际,Nurix Therapeutics行情,Nurix Therapeutics股票行情,Nurix Therapeutics股价,Nurix Therapeutics股市,Nurix Therapeutics股票价格,Nurix Therapeutics股票交易,Nurix Therapeutics股票购买,Nurix Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}